Cargando…
MicroRNA-425 and microRNA-155 cooperatively regulate atrial natriuretic peptide expression and cGMP production
AIMS: Atrial natriuretic peptide (ANP), secreted primarily by atrial cardiomyocytes, decreases blood pressure by raising cyclic 3’,5’-guanosine monophosphate (cGMP) levels and inducing vasorelaxation, natriuresis, and diuresis. Raising the level of ANP has been shown to be an effective treatment for...
Autores principales: | Vandenwijngaert, Sara, Ledsky, Clara D., Agha, Obiajulu, Wu, Connie, Hu, Dongjian, Bagchi, Aranya, Domian, Ibrahim J., Buys, Emmanuel S., Newton-Cheh, Christopher, Bloch, Donald B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919659/ https://www.ncbi.nlm.nih.gov/pubmed/29698509 http://dx.doi.org/10.1371/journal.pone.0196697 |
Ejemplares similares
-
MicroRNA miR-425 is a negative regulator of atrial natriuretic peptide
por: Arora, Pankaj, et al.
Publicado: (2013) -
Role of microRNA-21 and microRNA-155 as biomarkers for bronchial asthma
por: ElKashef, Sabrin Mohamed Mohamed Abd Elhamed, et al.
Publicado: (2020) -
Circulating plasma microRNA-126, microRNA-145, and microRNA-155 and their association with atherosclerotic plaque characteristics
por: Knoka, Evija, et al.
Publicado: (2020) -
MicroRNA 21 and microRNA 155 levels in resistant hypertension, and their relationships with aldosterone
por: Kara, Sonat Pınar, et al.
Publicado: (2021) -
Plasma expression of microRNA-425-5p and microRNA-451a as biomarkers of cardiovascular disease in rheumatoid arthritis patients
por: Taverner, Delia, et al.
Publicado: (2021)